Atriva is a privately funded company. Investors include:
- Meneldor, an investment fund focused on early stage biotech and pharma companies that (re)develop (New) Biological or Chemical Molecular Entities, that have outstanding technology with strong IP, address significant unmet medical needs and attractive markets.
- High-Tech Gründerfonds (HTGF), a Germany-based seed investor for innovative technologies and business models, successful in supporting the best founders whose ideas can revolutionize entire industries and improve people’s lives.
- Private investors and Atriva management and founders
Atriva works with leading academic institutions and research centers in its development activities.
The Company welcomes new development partnerships and collaborations with both industry and academia.